Skip to main content

Table 2 Comparison of clinical and genetic features between XIST-high and XIST-low groups

From: Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression

  XIST P
High (n = 31) Low (n = 31)
Age 30.23 ± 9.45 33.74 ± 10.35 0.1683
White blood cell 31.6 ± 17.29 41.56 ± 26.51 0.0849
Platelet 69.75 ± 10.97 64.46 ± 13.12 0.0902
Hemoglobin 8.83 ± 1.57 8.37 ± 2.04 0.3238
FAB 0.0018
 M3 6 18
 Non-M3 25 13
Risk stratification of cytogenetics 0.0173
 Good 5 15
 Intermediate 11 9
 Poor 15 7
  1. XIST, X Inactive-Specific Transcript; FAB, French-American-British